ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gastrointestinal Cancers: Gastric and Esophageal Cancers
Study on the application of modified negative pressure wound therapy with instillation in cervical anastomotic leakage after oesophageal cancer surgery
Provisionally accepted
- The People’s Hospital of Gaozhou, Gaozhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Aims: This study aims to explore the feasibility and safety of modified negative-pressure wound therapy with instillation (NPWTi) for the treatment of cervical anastomotic leakage (CAL) after oesophageal cancer surgery. Methods: A retrospective analysis was conducted on 17 patients who developed CAL after oesophageal cancer surgery and received modified NPWTi treatment at our hospital from 2021 to 2024. The primary outcome was the time to healing, defined as the number of days from the initiation of modified NPWTi to complete fistula closure. Secondary outcomes included wound odour improvement and patient comfort. Results: A total of 17 patient were collected (Table 1), including 10 men and seven women, with an average age of 73.71 ± 8.01 years. None received neoadjuvant therapy, and no patients had diabetes; preoperative albumin was 38.77 ± 3.58 g/L. The occurrence of CAL was noted at 8.88 ± 3.15 d (95% CI: 7.26 to 10.51 d) post-surgery. The modified treatment was commenced 0–12 d after CAL diagnosis, with the earliest case starting on the day of diagnosis. The mean duration of modified NPWTi was 10.88 ± 6.54 d (95% CI: 7.52 to 14.25 d). For the primary outcome, the time from treatment initiation to complete healing was 15.00 ± 7.26 d (95% CI: 11.27 to 18.73 d), with a minimum of five days. No mediastinal or pleural infections related to NPWTi occurred during the treatment. For the secondary outcomes, a significant improvement in wound odour was observed following the administration of the modified NPWTi (P<0.001) (Table 2), with an improvement rate of 100% (95% CI: 85-100%). During the treatment, the patients reported feeling comfortable and expressed overall satisfaction. Conclusion: Modified NPWTi demonstrated significant efficacy and convenience in treating CAL after oesophageal cancer surgery, benefiting both patients and healthcare providers with good safety profiles, thus warranting broader clinical application.
Keywords: negative-pressure wound therapy with instillation, Oesophageal cancer, Cervicalanastomotic leakage, Odour management, Negative-Pressure Wound Therapy
Received: 10 Jun 2025; Accepted: 05 Nov 2025.
Copyright: © 2025 Zhou, Huang, Guan, Xie, Lin, Wu, Chen, Li and Gong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Lanjuan Gong, gonglanjuan8161@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.